Volume 22, Number 3—March 2016
Research
Underestimation of Invasive Meningococcal Disease in Italy
Table 3
Distribution of rPCR and culture-based test results for Neisseria meningitidis for CSF and blood samples from a national register for molecular surveillance of invasive bacterial disease, Italy, 2007–2014*
Type of sample | No. samples/no. tested (%) |
|||
---|---|---|---|---|
Positive by rPCR | Negative by rPCR | Not tested by rPCR | Total† | |
CSF | ||||
Culture positive | 33 | 0 | 0 | 33/90 (36.7) |
Culture negative | 55 | 2 | 0 | 57/90 (63.3) |
Not tested with culture | 72 | 0 | 0 | 0 |
Total |
160/162 (98.8) |
2/162 (1.2) |
0 |
0 |
Blood | ||||
Culture positive | 16 | 0 | 10 | 26/107 (24.3) |
Culture negative | 37 | 10 | 34 | 81/107 (75.7) |
Not tested with culture | 51 | 2 | 0 | 0 |
Total |
104/116 (89.7) |
12/116 (10.3) |
0 |
0 |
Total, CSF or blood | ||||
Culture positive | 49 | 0 | 10 | 59/197 (29.9) |
Culture negative | 92 | 12 | 34 | 138/197 (70.1) |
Not tested with culture | 123 | 2 | 0 | 0 |
Total | 264/278 (95.0) | 14/278 (5.0) | 0 | 0 |
*A total of 162 CSF samples were tested with rPCR, and 90 were tested with culture-based methods. A total of 116 blood samples were tested with rPCR, and 107 were tested with culture-based methods. CSF, cerebrospinal fluid; rPCR, real-time PCR.
†Proportion of samples that were positive, negative, or not tested with culture-based methods.
1These authors contributed equally to this article.